Monthly Prescribing Reference2h
FDA: Ocaliva Linked to Severe Liver Injury in PBC Patients Without Cirrhosis
A higher risk of liver transplant and death was observed in Ocaliva-treated patients vs those who received placebo.
Monthly Prescribing Reference2h
Avatrombopag Under Review for Pediatric Immune Thrombocytopenia
A Prescription Drug User Fee Act target date of July 24, 2025 has been set for the sNDA application. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) ...
Monthly Prescribing Reference5h
Spinal Manipulation Lowers Likelihood of Butalbital Rx With Tension-Type Headache
(HealthDay News) — Adults receiving chiropractic spinal manipulative therapy (SMT) for tension-type headache have a significantly lower likelihood of butalbital prescription, according to a study ...
Monthly Prescribing Reference6h
RSV Burden Remains High in Young Children in the United States
The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA Pediatrics. Heidi L. Moline, MD, MPH, ...